Compare GPGI & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPGI | XENE |
|---|---|---|
| Founded | 2000 | 1996 |
| Country | United States | Canada |
| Employees | 977 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.2B |
| IPO Year | N/A | 2014 |
| Metric | GPGI | XENE |
|---|---|---|
| Price | $15.15 | $67.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $68.55 |
| AVG Volume (30 Days) | 1.5M | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,000.00 |
| Revenue This Year | $768.10 | N/A |
| Revenue Next Year | $126.25 | $2,496.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.22 | $30.00 |
| 52 Week High | $25.66 | $72.66 |
| Indicator | GPGI | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 54.25 | 69.54 |
| Support Level | $11.30 | $52.40 |
| Resistance Level | $17.50 | N/A |
| Average True Range (ATR) | 0.84 | 2.70 |
| MACD | -0.15 | 0.72 |
| Stochastic Oscillator | 31.06 | 67.89 |
GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.